Global Pharyngitis Treatment Market – Industry Trends and Forecast to 2030

Global Pharyngitis Treatment Market, By Drug Class (Macrolides, Beta Lactam, Tetracycline and Others), Mode of Delivery (Oral, Intravenous Intramuscular and Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Pharyngitis Treatment Market Analysis and Size

As per a recent research, about 70% of streptococcal infections of the respiratory tract are non-symptomatic, and these infections can cause serious non-supportive reaction. Pharyngitis is most commonly caused by viral infection such as common cold, influenza, and mononucleosis. It has been observed that self-medication for treating pharyngitis such as using antibiotics without knowing the exact cause deteriorates the disease condition and may last for several days.

Data Bridge Market Research analyses a growth rate in the pharyngitis treatment market in the forecast period 2023-2030. The expected CAGR of pharyngitis treatment market is tend to be around 4.9% in the mentioned forecast period. The market was valued at USD 2.20 billion in 2022, and it would grow upto USD 3.23 billion by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Pharyngitis Treatment Market Scope and Segmentation

Market Definition

Pharyngitis is a disorder that is typically characterized by the inflammation of the pharynx. It is most commonly known as sore throat. It causes pain, discomfort and scratchiness in the throat that further leads to difficulty in swallowing. The most common cause of its occurrence is due to viral infections such as common cold, influenza and others. The early treatment is essential to relive the pain. The typical symptoms includes sneezing, headache, fatigue, runny nose, body aches, chills and others.

Global Pharyngitis Treatment Market Dynamics

Drivers

• Increased Incidence of Pharyngitis

In 2020, more than 2.8 million people were reported to suffer from pharyngitis, with 1.1 million children under the age of 16. Pharyngitis is most common in kids under the age of 5 years. Adults also witness this condition but it develops slowly in them. Pharyngitis occurrences are quite high over the world, mainly in nations when antibiotics are extensively prescribed.

• Growing Awareness about Viral Infections

The increasing awareness about several viral infections led to the growth of the market. Flu, AIDS, and Ebola virus public awareness campaigns are also a vital component in raising public knowledge and, consequently, affecting segment growth. The World Health Organization (WHO) advises countries to maintain routine viral disease surveillance, specimens from surveillance sites for viral diseases and launches various campaigns for the diseases.

Opportunities

• Increase in GAS pharyngitis

As per the recent research, about 70% of streptococcal infections of the respiratory tract are non-symptomatic, and these infections can cause serious non-suppurative reaction. Even though acute pharyngitis is one of the most prevalent diseases among school-going children, GAS pharyngitis is uncommon. GAS pharyngitis and non-streptococcal pharyngitis have almost similar clinical appearances, making it difficult for physicians to differentiate between them without laboratory analysis.

• Increasing Demand of Antiviral Drugs

Pharyngitis treatment market for antiviral drugs is estimated to dominate the market by the end of 2030 and the segment is expected to witness exponential growth rate during the forecast period 2022-2030. It has been witnessed that Amoxicillin and penicillin are the most commonly prescribed antibiotics for strep throat and are likely to uphold the market growth.

Restraints/Challenges

• Lack of skilled professionals

The lack of qualified healthcare professional unable to perform the treatments could reduce the growth of the pharyngitis treatment market during the forecast period.

• Side-Effects of pharyngitis treatment

The adverse side-effects associated with the treatment process hinder the market growth. Effects such as infections, itching and also some drugs can lead to severe reactions

This pharyngitis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharyngitis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Pharyngitis Treatment Market Scope

The pharyngitis treatment market is segmented on the basis of drug class, mode of delivery, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Macrolides
• Beta Lactam
• Tetracycline
• Others

Mode of Delivery

• Oral
• Intravenous Intramuscular
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Pharyngitis Treatment Market Regional Analysis/Insights

The pharyngitis treatment market is analyzed and market size insights and trends are provided by drug class, mode of delivery, distribution channel and end-user as referenced above.

The major countries covered in the pharyngitis treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the presence of key manufacturers of the product is high and, increasing research and development activities.

Asia-Pacific dominates the market due to increased new research and developments on Pharyngitis Treatment market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Pharyngitis Treatment Market Share Analysis

The pharyngitis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pharyngitis treatment market.

Key players operating in the pharyngitis treatment market include:

• Bausch Health Companies Inc. (Canada.)
• Accord Healthcare (U.K.)
• Genentech, Inc (U.S.)
• PLIVA (Croatia)
• Pfizer Inc (U.S.)
• Amneal Pharmaceuticals LLC. (U.S.)
• Teva Pharmaceutical Industries Ltd (Israel)
• Mylan N.V. (U.S.)
• AbbVie Inc (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• ZAMBON COMPANY S.P.A (Italy)